Gts Securities LLC Ocugen, Inc. Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$0.98 - $1.95 $44,982 - $89,505	45,900 Added 97.25%	93,100 $92,000
Q2 2024 Aug 14, 2024	BUY	$1.18 - $1.98 $19,470 - $32,670	16,500 Added 53.75%	47,200 $73,000
Q1 2024 May 15, 2024	SELL	$0.5 - $1.83 $2,100 - $7,686	-4,200 Reduced 12.03%	30,700 $50,000
Q4 2023 Feb 14, 2024	SELL	$0.36 - $0.57 $2,232 - $3,533	-6,200 Reduced 15.09%	34,900 $19,000
Q3 2023 Nov 15, 2023	BUY	$0.4 - $0.62 $16,440 - $25,482	41,100 New	41,100 $16,000

124

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $184M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.